Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Mirum Pharmaceuticals
Mirum Pharmaceuticals
(MIRM)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Livmarli
Maralixibat
2021-09-29
2031-2040
Pruritus
,
Alagille syndrome
Cholbam
Cholic acid
2015-03-17
Zellweger syndrome
,
Inborn errors metabolism
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Cholic acid
inborn errors steroid metabolism
,
cholestasis
,
peroxisomal disorders
,
zellweger syndrome
,
infantile refsum disease
,
adrenoleukodystrophy
,
refsum disease
Maralixibat
overweight
,
healthy volunteers/patients
,
syndrome
,
alagille syndrome
,
substance withdrawal syndrome
,
biliary atresia
,
cholestasis
,
liver diseases
,
intrahepatic cholestasis
,
pruritus
Maralixibat chloride
overweight
,
healthy volunteers/patients
,
syndrome
,
alagille syndrome
,
liver cirrhosis
,
fibrosis
,
biliary liver cirrhosis
,
substance withdrawal syndrome
,
biliary atresia
,
sclerosing cholangitis
,
cholangitis
,
liver diseases
,
cholestasis
,
intrahepatic cholestasis
,
pruritus
Benzocaine
cerebrotendinous xanthomatosis
,
xanthomatosis
VOLIXIBAT
overweight
,
healthy volunteers/patients
,
non-alcoholic fatty liver disease
,
fatty liver
,
alcoholic fatty liver
,
cholangitis
,
pregnancy complications
,
cholestasis
,
intrahepatic cholestasis
,
sclerosing cholangitis
,
biliary liver cirrhosis
Sodium chloride
substance withdrawal syndrome
,
syndrome
,
alagille syndrome
,
liver diseases
,
cholestasis
SHP626
overweight
,
healthy volunteers/patients
,
non-alcoholic fatty liver disease
,
fatty liver
,
alcoholic fatty liver
,
cholangitis
,
pregnancy complications
,
cholestasis
,
intrahepatic cholestasis
,
sclerosing cholangitis
,
biliary liver cirrhosis
Arm1
pregnancy complications
,
cholestasis
,
intrahepatic cholestasis
,
sclerosing cholangitis
,
cholangitis
Arm2
pregnancy complications
,
cholestasis
,
intrahepatic cholestasis
,
sclerosing cholangitis
,
cholangitis
Kcl
non-alcoholic fatty liver disease
,
fatty liver
,
alcoholic fatty liver
Pbo
non-alcoholic fatty liver disease
,
fatty liver
,
alcoholic fatty liver
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use